📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Site-selective modification strategies in antibody-drug conjugates. (2021)

First Author: Walsh SJ

Attributed to: Advanced Linker Technology for Antibody-Drug Conjugates funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d0cs00310g

PubMed Identifier: 33290462

Publication URI: http://europepmc.org/abstract/MED/33290462

Type: Journal Article/Review

Volume: 50

Parent Publication: Chemical Society reviews

Issue: 2

ISSN: 0306-0012